Skip to main content
. 2016 Aug 24;54(9):2337–2342. doi: 10.1128/JCM.00897-16

TABLE 1.

HR HPV positivity of the Xpert HPV versus the GP5+/6+ EIA in women presenting for routine screening in Scotland (i.e., VALGENT-2 data set) for whom outcome data were availablea

Age and outcome GP5+/6+ EIA result Xpert HPV result
+ Total
All
    CIN2+ + 93 2 95
2 4 6
Total 95 6 101
    CIN3+ + 54 0 54
0 1 1
Total 54 1 55
    ≤CIN1 + 116 25 141
30 671 701
Total 146 696 842
≥30 yr
    CIN2+ + 36 1 37
2 2 4
Total 38 3 41
    CIN3+ 23 0 23
0 1 1
Total 23 1 24
    ≤CIN1 + 55 14 69
21 562 583
Total 76 576 652
a

Cross-tabulations are stratified according to women having CIN2+, CIN3+, or two consecutive negative cytology results and/or ≤CIN1. The top portion contains women of all ages, whereas the bottom section contains women ≥30 years of age.